Flagystatin product monograph
WebNov 1, 2024 · 1.0 Purpose. This Frequently Asked Questions (FAQ) document is intended to create a centralized location for Canadians and drug sponsors to find information about Health Canada-authorized Product Monographs. This document provides a broad range of information about Product Monographs, including general information, revisions to … WebThe drug FLAGYSTATIN contains a combination of these active pharmaceutical ingredients (APIs): 1 Methronidazole ... Structured Product Monograph (SPM) CA Medicine …
Flagystatin product monograph
Did you know?
WebA monograph is a written document that reflects the quality attributes of medicines approved by the U.S. Food and Drug Administration (US FDA). Some of these attributes … WebUSES: This product is used to treat certain types of vaginal infections (e.g., mixed fungal and bacterial infections). HOW TO USE: This product is for vaginal use only. Using the applicator, insert one ovule deep into the vagina, once daily before bedtime for 10 days; or take as directed by your doctor.
WebProduct Monograph) the following precau-tions mustbe bomein mind. Patients should be warned against consuming alcohol, ... Flagystatin creamdaily inserted deepinto the vagina, for 10 consecutive days. If after 10 daysof treatment acurehasnot beenachiev-ed a second 10-day course of treatment Weboral metronidazole was administered concomitantly with FLAGYSTATIN local treatment. In the course of clinical trials with FLAGYSTATIN, reactions, not necessarily related to the product, were observed: spots on the skin around the knees, welts all over the body, aching and swelling of wrists and ankles, pruritis, headache, coated tongue and fatigue.
WebHypersensitivity to FLAGYSTATIN (metronidazole and nystatin); or any of its constituents, or to imidazoles. Combined treatment with oral metronidazole should be avoided in … WebProduct Monograph ONDISSOLVE® ODF (ondansetron) Page 1 of 39 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrONDISSOLVE®ODF OndansetronOrally Disintegrating Film Orally Disintegrating Film, 4 mg and 8 mg, oral Antiemetic 5-HT3receptor antagonist ATC code A04AA01 Takeda …
WebDr. Robert Killian answered. General Practice 30 years experience. Flagystatin: This is a drug that is a combination of Metronidazole and Nystatin and is available by prescription. Created for people with ongoing healthcare needs …
WebSep 12, 2013 · 1.1 Purpose. The purpose of this guidance document is to assist sponsors in developing product monographs with acceptable format and content. The product monograph is an integral part of New Drug, Supplement to a New Drug, Abbreviated New Drug and Supplement to an Abbreviated New Drug Submissions. ontploffing hoofdWebAug 30, 2024 · A Verified Doctor answered. Family Medicine 49 years experience. 3 days: This is an antifungal vaginal suppositry and should cure your infection within 2-3 days. Created for people with ongoing healthcare needs but benefits everyone. Learn how we can help. 3.5k views Answered >2 years ago. ios writeutteranceWebHypersensitivity to FLAGYSTATIN (metronidazole and nystatin); or any of its constituents, or to imidazoles. Combined treatment with oral metronidazole should be avoided in cases of active neurological disorders or a history of blood dyscrasia, hypothyroidism or hypoadrenalism unless, in the opinion of the physician, the benefits outweigh the … ios x downloadsWebJun 1, 2015 · glycerides of saturated fatty acid (hard fat). The nonmedicinal ingredients of FLAGYSTATIN cream are: glycerin, glyceryl monostrearate, methylparaben, … ontplofte bomWebPRODUCT MONOGRAPH Pr FLAGYSTATIN® (500 mg metronidazole and 100,000 IU nystatin) Vaginal Ovules Vaginal Cream Trichomonacide – Moniliacide sanofi-aventis Canada Inc. 2150 St. Elzear Blvd.West Laval, Quebec H7L 4A8 Submission Control No.: 155380 Date of Revision: August 2, 2012 s-a 4.0 Version dated August 2, 2012 Page 1 … ontploffing turnhout vandaagWebPRODUCT MONOGRAPH PrLOVASTATIN Lovastatin Tablets, USP 20 mg and 40 mg Lipid Metabolism Regulator SANIS HEALTH INC. DATE OF REVISION: 1 President's Choice Circle December 21, 2024 Brampton, Ontario L6Y 5S5 Control No.: 211572 ios written inWebAn over-the-counter antifungal drug product in a form suitable for topical administration is generally recognized as safe and effective and is not misbranded if it meets each of the conditions in this OTC monograph and each general condition established in 21 CFR 330.1. § M005.3 Definitions . As used in this OTC monograph: (a) Antifungal. ios-xe 17.3.3 memory leak